Whereas Song et al. reported that a low concentration of ApoA-II was associated with an increased risk for cognitive decline in normal individuals [57], Lehallier et al. described increased ApoA-II levels in patients with the progression of mild cognitive impairment to AD [58]. This evidence concerns the gene APOA2 and Mental deterioration.